DENVER, July 5 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health, medical information technology company, will be presenting at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference to be held at the Mandarin Oriental Hotel located at the Time-Warner Center in New York City. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global Med's Chairman and CEO, Mick Ruxin, M.D., will provide a Company overview, along with an update on Global Med's current operations and new developments, on Thursday, July 12th from 2:30 to 3:00 PM. Time for questions and answers will follow the presentation. Unterberg, Towbin will also arrange one-on-one meetings with potential investors. For further information on the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference, please contact Ms. Leigh Simons at Unterberg, Towbin at (212) 389-8127 or e-mail: . About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R)* advanced transfusion management system provide Vein-to- Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R), Inc. CONTACT: Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies(R), Inc., +1-303-238-2000; or investors, Paul M. Holm of H.L. Lanzet, +1-212-888-4570, , for Global Med Technologies(R), Inc. Web site: http://www.globalmedtech.com/ http://www.wyndgate.com/ http://www.peoplemed.com/

Copyright